clinical trial · NCT07596173
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years
Diphtheria-Tetanus-acellular Pertussis VaccinesdTpa vaccine
brief summary
The purpose of the study is to assess the immune response, reactogenicity and safety of a booster dose of dTpa vaccine 1 month after vaccination in healthy Japanese participants aged 11 to \<13 years.
started
Jun 29, 2026
primary completion
Oct 14, 2026
completion
Oct 14, 2026
last updated
Jul 28, 2026
official title
A Phase 3, Non-randomized, Single-arm, Open-label Study to Assess the Immunogenicity, Safety and Reactogenicity of Combined Reduced-antigen-content Diphtheria, Tetanus and Acellular Pertussis (dTpa) Vaccine, Administered as a Booster Dose in Healthy Japanese Adolescents Aged 11 Years to <13 Years
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol